Wakefield Daniel V, Venable Garrett T, VanderWalde Noam A, Michael L Madison, Sorenson Jeffery M, Robertson Jon H, Cunninghan David, Ballo Matthew T
Department of Radiation Oncology, University of Tennessee Health Science Center, Memphis, Tennessee, United States.
Department of Neurosurgery, University of Tennessee Health Science Center, Memphis, Tennessee, United States.
J Neurol Surg B Skull Base. 2017 Jun;78(3):251-255. doi: 10.1055/s-0036-1597986. Epub 2017 Jan 23.
This case series investigates management of glomus jugulare (GJ) tumors utilizing definitive and salvage Gamma Knife stereotactic radiosurgery (GKSRS). A retrospective chart review was performed to collect data. Statistical analysis included patient, tumor, and treatment information. From 1996 to 2013, 17 patients with GJ received GKSRS. Median age was 64 years (range, 27-76). GKSRS was delivered for definitive treatment in eight (47%) and salvage in nine (53%) patients. Median tumor volume was 9.8 cm (range, 2.8-42 cm ). Median dose was 15 Gy (range, 13-18 Gy). Median follow-up was 123 months (range, 38-238 months). Tumor size decreased in 10 (59%), stabilized in 6 (35%), and increased in 1 patient (6%). Overall neurological deficit improved in 53%, stabilized in 41%, and worsened in 6% of patients. Overall cause-specific survival was 100%, and actuarial local control was 94%. Eighty-eight percent of patients without prior resection experienced neurologic deficit improvement, while 25% of patients with prior resection experienced neurologic improvement ( = 0.02). Gamma Knife radiosurgery provides effective long-term control of GJ and overall improvement or stabilization of neurological deficit in most patients. Patients with prior resection are less likely to experience improvement of neurologic deficit.
本病例系列研究了采用伽玛刀立体定向放射外科手术(GKSRS)对颈静脉球瘤(GJ)进行确定性治疗和挽救性治疗的情况。进行了一项回顾性病历审查以收集数据。统计分析包括患者、肿瘤和治疗信息。1996年至2013年,17例GJ患者接受了GKSRS治疗。中位年龄为64岁(范围27 - 76岁)。8例(47%)患者接受GKSRS进行确定性治疗,9例(53%)患者接受挽救性治疗。中位肿瘤体积为9.8 cm³(范围2.8 - 42 cm³)。中位剂量为15 Gy(范围13 - 18 Gy)。中位随访时间为123个月(范围38 - 238个月)。10例(59%)患者肿瘤大小减小,6例(35%)患者肿瘤大小稳定,1例(6%)患者肿瘤增大。53%的患者总体神经功能缺损得到改善,41%的患者病情稳定,6%的患者病情恶化。总体特定病因生存率为100%,精算局部控制率为94%。88%未接受过先前切除术的患者神经功能缺损得到改善,而25%接受过先前切除术的患者神经功能得到改善(P = 0.02)。伽玛刀放射外科手术可对GJ提供有效的长期控制,并使大多数患者的神经功能缺损总体得到改善或稳定。接受过先前切除术的患者神经功能缺损改善的可能性较小。